BIOMAT Database Logo BIOMAT Database Logo

Long-term follow-up of ABO-incompatible renal transplant recipients. 1999

H Karakayali, and G Moray, and A Demirağ, and M Turan, and N Bilgin, and M Haberal
Başkent University Faculty of Medicine, Department of General Surgery and Transplantation, Ankara, Turkey.

UI MeSH Term Description Entries
D007166 Immunosuppressive Agents Agents that suppress immune function by one of several mechanisms of action. Classical cytotoxic immunosuppressants act by inhibiting DNA synthesis. Others may act through activation of T-CELLS or by inhibiting the activation of HELPER CELLS. While immunosuppression has been brought about in the past primarily to prevent rejection of transplanted organs, new applications involving mediation of the effects of INTERLEUKINS and other CYTOKINES are emerging. Immunosuppressant,Immunosuppressive Agent,Immunosuppressants,Agent, Immunosuppressive,Agents, Immunosuppressive
D008297 Male Males
D001787 Blood Group Incompatibility An antigenic mismatch between donor and recipient blood. Antibodies present in the recipient's serum may be directed against antigens in the donor product. Such a mismatch may result in a transfusion reaction in which, for example, donor blood is hemolyzed. (From Saunders Dictionary & Encyclopedia of Laboratory Medicine and Technology, 1984). ABO Compatibility,ABO Incompatibility,Blood Group ABO Incompatibility,Blood Type Incompatibility,Rh Compatibility,Rh Incompatibility,ABO Compatibilities,ABO Incompatibilities,Blood Group Incompatibilities,Blood Type Incompatibilities,Compatibility, ABO,Compatibility, Rh,Incompatibilities, Blood Group,Incompatibility, ABO,Incompatibility, Blood Group,Incompatibility, Blood Type,Incompatibility, Rh,Rh Compatibilities,Rh Incompatibilities
D004359 Drug Therapy, Combination Therapy with two or more separate preparations given for a combined effect. Combination Chemotherapy,Polychemotherapy,Chemotherapy, Combination,Combination Drug Therapy,Drug Polytherapy,Therapy, Combination Drug,Chemotherapies, Combination,Combination Chemotherapies,Combination Drug Therapies,Drug Polytherapies,Drug Therapies, Combination,Polychemotherapies,Polytherapies, Drug,Polytherapy, Drug,Therapies, Combination Drug
D005260 Female Females
D005500 Follow-Up Studies Studies in which individuals or populations are followed to assess the outcome of exposures, procedures, or effects of a characteristic, e.g., occurrence of disease. Followup Studies,Follow Up Studies,Follow-Up Study,Followup Study,Studies, Follow-Up,Studies, Followup,Study, Follow-Up,Study, Followup
D006084 Graft Rejection An immune response with both cellular and humoral components, directed against an allogeneic transplant, whose tissue antigens are not compatible with those of the recipient. Transplant Rejection,Rejection, Transplant,Transplantation Rejection,Graft Rejections,Rejection, Graft,Rejection, Transplantation,Rejections, Graft,Rejections, Transplant,Rejections, Transplantation,Transplant Rejections,Transplantation Rejections
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000017 ABO Blood-Group System The major human blood type system which depends on the presence or absence of two antigens A and B. Type O occurs when neither A nor B is present and AB when both are present. A and B are genetic factors that determine the presence of enzymes for the synthesis of certain glycoproteins mainly in the red cell membrane. ABH Blood Group,ABO Blood Group,ABO Factors,Blood Group H Type 1 Antigen,H Blood Group,H Blood Group System,ABO Blood Group System,Blood Group, ABH,Blood Group, ABO,Blood Group, H,Blood-Group System, ABO,Factors, ABO,System, ABO Blood-Group
D012189 Retrospective Studies Studies used to test etiologic hypotheses in which inferences about an exposure to putative causal factors are derived from data relating to characteristics of persons under study or to events or experiences in their past. The essential feature is that some of the persons under study have the disease or outcome of interest and their characteristics are compared with those of unaffected persons. Retrospective Study,Studies, Retrospective,Study, Retrospective

Related Publications

H Karakayali, and G Moray, and A Demirağ, and M Turan, and N Bilgin, and M Haberal
Long-term follow-up study of renal transplant recipients.
August 1994, Transplantation proceedings,
H Karakayali, and G Moray, and A Demirağ, and M Turan, and N Bilgin, and M Haberal
Long-term follow-up of renal transplant recipients using immunologic monitoring.
March 1979, Transplantation proceedings,
H Karakayali, and G Moray, and A Demirağ, and M Turan, and N Bilgin, and M Haberal
Azathioprine withdrawal in renal transplant recipients. A long-term follow-up.
July 1984, Transplantation,
H Karakayali, and G Moray, and A Demirağ, and M Turan, and N Bilgin, and M Haberal
Long-term outcome of ABO-incompatible renal transplantation.
November 2001, The Urologic clinics of North America,
H Karakayali, and G Moray, and A Demirağ, and M Turan, and N Bilgin, and M Haberal
Evaluation of long-term follow-up of glomerular function in renal transplant recipients.
January 1998, Transplant international : official journal of the European Society for Organ Transplantation,
H Karakayali, and G Moray, and A Demirağ, and M Turan, and N Bilgin, and M Haberal
Long-term functional follow-up of lung transplant recipients.
June 1990, Clinics in chest medicine,
H Karakayali, and G Moray, and A Demirağ, and M Turan, and N Bilgin, and M Haberal
Long-term follow-up of renal transplant recipients treated with losartan for post-transplant erythrosis.
January 1998, Transplant international : official journal of the European Society for Organ Transplantation,
H Karakayali, and G Moray, and A Demirağ, and M Turan, and N Bilgin, and M Haberal
Determinants of renal function in pediatric heart transplant recipients: long-term follow-up study.
February 2007, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation,
H Karakayali, and G Moray, and A Demirağ, and M Turan, and N Bilgin, and M Haberal
Prospective study and long-term follow-up of liver damage in renal transplant recipients.
February 1987, Transplantation proceedings,
H Karakayali, and G Moray, and A Demirağ, and M Turan, and N Bilgin, and M Haberal
Long-term follow-up of cyclosporine-treated cardiac transplant recipients.
June 1990, Transplantation proceedings,
Copied contents to your clipboard!